To receive continuing education (CE) credit, you must complete the virtual lecture, CE posttest and activity evaluation at the link below.
Access: Virtual Lecture (synchronized audio and slides)
CE Credit Available Until: March 02, 2018
Hematology, oncology and BMT nurses; hematology, oncology and BMT social workers at intermediate to advanced levels of practice, experience and licensure; transplant center coordinators; payer case managers and other allied health professionals.
In this free webinar, pediatric oncology experts will describe: current and emerging therapies for patients with ALL, the risks and benefits of treatment options, the impact of timely referral for blood and marrow transplant (BMT) consultation and the psychosocial impact of diagnosis and treatment.
After completing this activity, the participant should be better able to:
- Describe the latest treatments for acute lymphoblastic leukemia (ALL) for pediatric, and adolescent and young adult (AYA) patients, including current and emerging therapies
- Explain the impact of timely blood and marrow transplantation (BMT) referral
- Describe the psychosocial impact of diagnosis and treatment, and strategies to support patients and families
- Identify educational programs and resources to support patients and caregivers
Jennifer Reichek, MD, MSW
Attending Physician, Hematology, Oncology, Transplant, Ann & Robert H. Lurie Children’s Hospital of Chicago
Director, STAR (Survivors Taking Action and Responsibility) Program, Ann & Robert H. Lurie Children’s Hospital of Chicago
Assistant Professor, Northwestern University Feinberg School of Medicine
Kimberly Kasow, DO
UNC Lineberger Comprehensive Cancer Center member
Director of Pediatric Bone Marrow Transplant Program and Professor in the Department of Pediatrics in the Division of Hematology-Oncology at UNC-Chapel Hill
Joni Lamb, LCSW
Senior Social Worker Oncology, Ann & Robert H. Lurie Children's Hospital of Chicago
Sponsors and Supporters
Sponsored jointly by The Leukemia & Lymphoma Society and the National Marrow Donor Program®/Be The Match®.